Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lijun Xie has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dimethylamino Rofecoxib with Four Polymorphic Crystals as a New Multi-stimulus Responsive Material

    by Yanbing Ke, Xia Wang, Tong Wu, Wei Liu, Yongbo Wei, Hongmei Wu, Bing Xu, Fangfei Lu, Hong Chen, Shijie Zhen, et al.

  • Dual-Conformation Stimuli-Responsive Material and Its High Contrast Imaging

    by Jingming Zhou, Xia Wang, Hongmei Wu, Hong Chen, Wei Liu, Shijie Liu, Weiwei Zhang, Tong Wu, Xinli Wang, Zujin Zhao, et al.

  • Facile transformation of rofecoxib into a novel near-infrared AIEgen for real-time dynamic monitoring of lipid droplet metabolism

    by Tao Dai, Renfu Li, Tong Wu, Xia Wang, Xinli Wang, Weiwei Zhang, Xueyuan Chen, Zhuo Chen, Lijun Xie

    A novel AIEgen with two-photon absorption properties derived from a one-step modification of rofecoxib for real-time visualization of LD dynamics.

  • Novel Rapamycin Derivative With Lower Immunosuppressive Activity and Cytotoxicity Extends Lifespan of Caenorhabditis elegans

    by Kualiang Li, Qingqin Li, Lijun Xie, Jiayin Ying, Xiaqin Chen, Ying Liu, Guoxin Yang

    Rapamycin is a multifunctional drug derived from Streptomyces hydroscopicus with several biological activities, such as anti‐fungal, anti‐tumor, anti‐proliferation, and immunosuppressive activities. In recent years, rapamycin and its derivatives have attracted widespread attention in the field of lifespan extension or anti‐aging. In view of the strong immunosuppressive activity and certain cytotoxicity of rapamycin itself, it may cause some potential adverse reactions for long‐term use. In this study, a rapamycin derivative with lower immunosuppressive activity and cytotoxicity was selected for further study. Based on the analysis of lifespan extension, the rapamycin thiazole‐derivative FIM‐X8 showed a strong effect on extending the lifespan of Caenorhabditis elegans . The influences on the survival of nematodes under high temperature or oxidation conditions were also analyzed. Further studies on the longevity‐associated genes showed that lifespan extension induced by rapalogs was comprehensively regulated by multiple metabolic pathways, and it was closely related to the key role of mTOR in the regulation of growth and metabolism. Genes rsks‐1 and daf‐12 mutant nematode strains were selected to elucidate the mechanism of lifespan extension, and we found that great importance was attached to gene rsks‐1 when FIM‐X8 extended the lifespan of C. elegans .


  • AIE Fluorescent Probes Constructed by Introducing Acceptor‐Derived Microbial Metabolite Staurosporine

    by Jingming Zhou, Xia Wang, Shijie Liu, Yuqiu Ye, Xuejing Su, Tong Wu, Yusheng Lu, Xiaoping Wu, Lijun Xie

    The aggregation‐caused quenching (ACQ) phenomenon limits the bioimaging application of traditional fluorescent probes. To address this, we developed a novel strategy to convert ACQ‐type bioactive Staurosporine analogues into aggregation‐induced emission (AIE) luminogens by constructing a donor–acceptor system via the introduction of cyano units as strong electron‐withdrawing groups. First, we successfully developed a novel fluorescent scaffold based on the skeleton of Staurosporine, which is a kind of microbial secondary metabolite. Next, we synthesized three derivatives ( STY1 – 3 ) by introducing a new rotor via one‐step structural modification. These three compounds exhibited tunable AIE fluorescence and retained significant bioactivity. Cellular imaging demonstrated their capacity to outline cell contours with low background interference, while cytotoxicity assays revealed potent antitumor activity against NCI‐N87 and MCF‐7 cell lines. This work provides a design method for developing bioactive AIE probes from natural ACQ scaffolds.

  • Novel hydrazone-based photoactivatable fluorescent probes with ultra-high photo-degradation efficiencies and their application in dynamic mitochondrial targeted bioimaging

    by Jingming Zhou, Xia Wang, Xiaoxuan Ming, Xuejing Su, Yanbing Ke, Wei Liu, Tong Wu, Yusheng Lu, Haipeng Xu, Lijun Xie

    Photoactivatable fluorophores are useful tools in live cell bioimaging due to precise spatial and temporal control of fluorescent materials. Herein, we propose two new rhodamine 6G-derived photoactivatable fluorophores LZ1 and LZ2 with novel hydrazone caging groups that can quench the fluorescence of rhodamine 6G. Then, LZ1 and LZ2 underwent photoactivation under visible-light (530 nm) irradiation, and the post-activation forms exhibited bright fluorescence. Meanwhile, mechanism studies indicated that the hydrazone caging group was employed as a fluorescence quencher due to its photoinduced electron transfer (PET) effect. Interestingly, LZ1 and LZ2 demonstrate ultra-high photodegradation efficiencies of 95.9% and 73.3% in releasing fluorophores, respectively. Moreover, LZ1 and LZ2 can specifically locate the mitochondria in cell imaging, and their uncaging processes were clearly identified. Overall, these photocaged dyes are highly efficient, and versatile, offering promising applications in the construction of photoactivatable fluorescent probes as a new type of photocage.

  • The development of novel AIE-active staurosporine-based fluorescent probes with theranostic potential

    by Nannan Chen, Yuqiu Ye, Longfeng Zhang, Xia Wang, Shijie Liu, Xiaoming Chen, Tong Wu, Jingming Zhou, Haipeng Xu, Lijun Xie

    The research on the photophysical properties and structure–activity relationships of staurosporine derivatives is highly meaningful to develop staurosporine as a new type of anticancer therapeutic. In this work, three staurosporine derivatives (Y1, Y2 and Y3) with aggregation-induced emission (AIE) characteristics and theranostic potential were designed and synthesized by using cyano electron-withdrawing groups to modify the natural staurosporine. These new staurosporine derivatives exhibited AIE properties and solvatochromism. The photoluminescence quantum yields of Y1, Y2, and Y3 are enhanced by factors of 4.3, 5.9, and 7.1 in the aggregated state, respectively. These fluorescent probes also showed protein kinase C (PKC) inhibitory activity and anti-cancer activity for NCI-N87 and MCF-7 cells. The docking calculations revealed that the probes retained antitumor activity by preserving key interactions between the staurosporine core and the protein kinase C (PKC). Cellular imaging demonstrated bright fluorescence emission within tumor cells. This work provides a design strategy for integrating fluorescence performance and pharmacological activity, offering a promising approach for cancer diagnosis and therapy.

  • A Rofecoxib‐Derived Theranostic Probe and Its Combination With PD‐1 Inhibitor for High‐Efficiency Cancer Therapy

    by Xinli Wang, Xia Wang, Xuejing Su, Zexin Wang, Yongxiao Sun, Lijun Xie, Xiaoyan Lin

    The development of theranostic probes with tumor‐specific targeting and high therapeutic efficacy remains a pivotal challenge in precision oncology. Herein, we have successfully developed a new cyclooxygenase‐2 (COX‐2)‐targeted probe compound 2 derived from Rofecoxib. Compound 2 facilitated tumor visualization by a sixfold fluorescence enhancement upon COX‐2 binding, while it exhibited minimal background fluorescence under physiological conditions. Moreover, compound 2 monotherapy achieved 53% tumor regression ( p < 0.01). When combined with a programmed cell death protein 1 (PD‐1) inhibitor (RMP1‐14), concurrent blockade of the COX‐2/prostaglandin E2 (PGE2) and PD‐1/programmed death‐ligand 1 (PD‐L1) axes achieved 95% tumor regression ( p < 0.001). Compound 2 involves activating fluorescence by targeting tumor markers COX‐2 as well as enhancing therapeutic efficacy. We believe this approach could provide insights for advancing cancer diagnosis and treatment technologies.

  • Natural Staurosporine Derivatives with Fluorescence for Cancer Theranostics

    by Kualiang Li, Wei Liu, Tong Wu, Yongbo Wei, Ying Liu, Jingming Zhou, Li Chen, Jian Zhou, Yusheng Lu, Haipeng Xu, et al.

    In recent years, developing effective theranostic agents for precise cancer treatment has been one of the most prevalent strategies. Herein, three staurosporine derivatives, MCY‐STS, ECY‐STS, and ICY‐STS, synthesized through minor modifications of natural staurosporine, are reported. These derivatives not only exhibit attractive fluorescence properties, including solvatochromism and dual‐state (solution and solid) emission, but also demonstrate potent protein kinase C inhibitory activity and anticancer effects against NCI‐N87, MCF‐7, and SK‐OV‐3 cell lines. Theoretical calculation analyses, including density functional theory calculations, molecular docking, and molecular dynamics simulations, are employed to elucidate their protein–ligand interactions and luminescence mechanisms. Further investigations reveal that ECY‐STS significantly inhibits tumor growth while illuminating tumor tissues for therapy visualization. Collectively, these modified fluorescent staurosporine derivatives, particularly ECY‐STS, represent promising theranostic agents that provide a novel strategy for cancer imaging and treatment in humans.